*Tiotropium RespimatÂ® for use in asthma is currently being reviewed by regulatory authorities; it is approved as SpirivaÂ® RespimatÂ® for use in asthma in Chile, Colombia, Ecuador, Norway, Russia and Thailand and accepted in the EU.